Stelios Elia is a Managing Director at BC Partners, one of the leading Private Equity firms in Europe and N. America. BC Partners has invested in large companies for nearly 35 years and has executed some of the largest and most complicated buy-out transactions in South East Europe, including Greece, Italy and Bulgaria. Stelios joined BC Partners in 2008. Before that he spent two years with McKinsey in London. At BC Partners, Stelios covers and invests in the TMT as well as the Consumer and Retail sectors. He is a member of the Board of Directors of Pharmathen (an innovative drug developer), United Group (the leading multi-play telecoms and media provider in South East Europe) and Acuris (a specialist financial news and data provider, formerly known as Mergermarket). Stelios is also a member of the Future Leaders Committee of the Impetus Private Equity Foundation in London and was voted in 2019 by Financial News as one of the Rising Stars of European Private Equity. Stelios holds MA and MEng degrees from Cambridge University where he graduated top of his class and received his MBA as a Baker Scholar from Harvard Business School. He has co-authored Harvard Business School case studies on Cyprus, addressing the development of the Cypriot economic model and the 2012-13 local financial crisis.